Home News

ROVI completes the manufacture of the first batches of Moderna vaccine

Laboratorios Farmacéuticos Rovi, S.A. (BME -Spanish Stock Exchanges and Markets: ROVI), a pan-European specialised company engaged in the research, development and marketing of biological specialties and a manufacturer with a high degree of technological

Wed, 13/01/2021 - 17:03 0 min
Download related document
No votes yet
 
Related
Awarded a grant co-funded by the the European Union's European Regional...
0 min
31/03/2018
2017 Results press release
Download our press release published on 20 February to find out the financial results for the full year 2017.
1 min
20/02/2018
2017 Results presentation
Operating income, growth figures, profitability and how our products have behaved.
1 min
20/02/2018